Prevest Denpro Ltd. · BSE:PREVEST
Prevest Denpro — Q1 FY2025 Earnings Presentation
22 slides from Prevest Denpro's earnings presentation, Aug 17, 2024
Slide 1: Submission of Investor Presentation to BSE
August 17, 2024 To The Secretary, Listing Department BSE Limited(SME), Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai-400 001 Dear Sir, Sub: Submission of Investor Presentation to be made to Analysts/Investors Please find enclosed herewith the investor presentation to be made to Analysts/Inve
Slide 2: Empowering Smiles Worldwide with Innovative Dental Solutions
Empowering Smiles Worldwide with Innovative Dental Solutions Q1 FY 2025
Slide 3: Inside the Presentation
Inside the Financial Highlights Presentation Balance Sheet Summary Cash Flow Summary Income Statement About the Business - Strategic Production Selection Criteria - Our Evolving Business Model Quarterly Highlights - Top 10 Revenue-Generating Products P&L Summary Management Commentary - Prevest Resea
Slide 4: Strategic Product Selection Criteria
ABOUT THE COMPANY Prevest DenPro Innovation & Strategic Technological Advancement Prioritize innovative products Product Market Demand & that leverage cutting-edge technology to meet emerging market needs. Regulatory Compliance Selection Growth Potential & Quality Standards Target products with stro
Slide 5: Our Evolving Business Model
Our Evolving Prevest DenPro Business Model Diversification Strategy Prevest Denpro Limited is committed to expanding its Sustainability a n d Efficiency market reach and product portfolio. Our evolving We are dedicated to integrating sustainable business model emphasizes diversification across pract
Slide 6: Top 10 Revenue-Generating Products
Q1 FY25 Prevest DenPro Top 10 Revenue-Generating Products Alvocure 12g Cal Lc Intro Endoseal Fusion Universal Fusion Crysta Orthodontic Pack 2x2g Adhesive Kit Fusion I Seal Fusion Flo Crysta Luting Crysta Silver Crysta Restorative Economy Pack Combo Kit 4x2g 4x2g
Slide 7: Prevest Research Centre
Prevest Research Centre Innovation & Development: Creates advanced dental materials and technologies. Quality Enhancement: Ensures high safety, efficacy, and durability. Customization: Delivers tailored solutions for specific client needs. Faster Time-to-Market: Accelerates product development and l
Slide 8: Accreditations that speak to our Comprehensive Standards
Accreditations that speaks to our Prevest DenPro Comprehensive Standards Conformity with Conformity to sell our European Standards Conformity with ISO Standard For Medical products in US Market Devices Conformity to Medical Device Single Conformity to sell our Audit Program for USA, Canada & product
Slide 9: Strategic Technical Research & Tie-Up
Strategic Technical Prevest DenPro Research & Tie-Up Prevest DenPro Limited has partnered with esteemed dental and technical institutions across India to advance research and innovation in dentistry and oral care. Collaborations with institutions like Terna Dental College & Hospital, Malla Reddy Den
Slide 10: Top 5 Exporting Countries
Q1 FY25 Prevest DenPro Top 5 Exporting Countries United Kingdom Indonesia Saudi Arabia Morocco Lebanon 17.03% 10.13% 9.12% 7.43% 3.60% Revenue Revenue Revenue Revenue Revenue
Slide 11: Revenue Breakdown: Domestic vs Export Sales
Prevest DenPro Revenue Breakdown Domestic Sales vs. Export Sales 2023-24 2023-24 2024-25 Prev Qtr Particulars Qtr on Qtr /Current Qtr Qtr 1 Qtr 4 Qtr 1 Domestic Sale 4.98 Cr 5.74 Cr 6.20 Cr 24.50% 8.01% Sale Export 8.29 Cr 10.40 Cr 6.93 Cr -16.41% -33.37% Revenue from Sale 13.28 Cr 16.16 Cr 13.13 Cr
Slide 12: Financial Highlights
Prevest DenPro Financial Highlights
Slide 13: Balance Sheet Summary
FINANCIAL HIGHLIGHTS Prevest DenPro Balance Sheet Summary (INR cr) As on 31st March FY20 FY21 FY22 FY23 FY24 Equity share capital 0 0 12 12 12 Preference Share Capital 0 0 0 0 0 Reserves & surplus 14 22 45 61 77 Shareholders funds 15 22 57 73 89 Borrowings 1 2 1 1 0 Net Deferred tax 0 0 0 0 1 Minori
Slide 14: Cash Flow Statement
FINANCIAL HIGHLIGHTS Prevest DenPro Cash Flow Statement Year to March FY20 FY21 FY22 FY23 FY24 Net profit 5 7 12 16 16 Add: Depreciation 1 0 1 1 1 Add: Misc expenses written off 0 0 -1 -2 -2 Add: Deferred tax 0 0 0 0 0 Gross cash flow 6 8 11 15 15 Less: Changes in W. C. 1 -1 6 4 4 Operating cash flo
Slide 15: Income Statement
FINANCIAL HIGHLIGHTS Prevest DenPro Income Statement (INR crs) Year to March FY20 FY21 FY22 FY23 FY24 Income from operations 23 28 38 50 56 Direct costs 7 8 10 13 14 Power & Fuel 0 0 0 0 0 Employee costs 5 5 7 8 9 Other expenses 6 7 7 9 13 Total operating expenses 18 20 23 30 36 EBITDA 5 9 15 20 20
Slide 16: Quarterly Highlights
Quarterly Highlights P&L Summary Management Commentary
Slide 17: Profit & Loss Summary
QUARTERLY HIGHLIGHTS Prevest DenPro Profit & Loss Summary 1.58% -3.43% -10.08% YoY Change Revenue EBITDA PAT PARTICULARS ( ₹ I N C RORES) Q1FY24 Q4FY24 Q1FY25 YoY Change QoQ Change Revenue from Operations 1339.40 1623.51 1335.56 -0.29 -17.74 Total Income 1399.92 1707.50 1421.99 1.58 -16.72 Operating
Slide 18: Management Commentary
QUARTERLY HIGHLIGHTS Prevest DenPro Management Commentary Dear Investors, As we review the results of the first quarter of FY25, I want to be upfront about our Q1FY25 performance, which did not meet our expectations. While our domestic business continues to grow strongly with 25% year-on-year growth
Slide 19: Management Commentary
QUARTERLY HIGHLIGHTS Prevest DenPro Management Commentary This quarter has been challenging for us, with our numbers reflecting a less impressive performance compared to previous periods, which is mainly because of (1) higher depreciation due to commencement of new departments (R&D, Expansion), (2)
Slide 20: Management Commentary
QUARTERLY HIGHLIGHTS Prevest DenPro Management Commentary In Q1 FY25, our revenue increased by a modest 1.48% year-on-year, but there was a 16.85% decline quarter- on-quarter. While this performance did not meet our expectations, I want to assure you that we are taking deliberate and strategic actio
Slide 21: Market Statistics
Prevest DenPro Market Statistics Shareholding Pattern CURRENT MARKET PRICE ₹ 547 52 WEEK HIGH/LOW ₹ 673 / 332 MARKET CAPITALIZATION ₹ 656.56 Cr SHARES OUTSTANDING 1.20 Cr Promoter 73.60% Public 26.40% BSE SCRIP CODE 543363 Shareholding Data as on 30th June 2024 Market Price Data as on 16th August 20
Slide 22: Thank You
Prevest DenPro Thank You www.prevestdenpro.com www.prevestdirect.com